Trinity Biotech reported $11.07M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
J&J USD 25.31B 1.21B Jun/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Siemens EUR 20.79B 1.03B Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Tosoh JPY 274.17B 10.33B Jun/2026
Trinity Biotech USD 11.07M 3.24M Dec/2025
Veracyte USD 150.32M 11.25M Jun/2026